NIH begins study of COVID-19 vaccination during pregnancy and postpartum

(NIH/National Institute of Allergy and Infectious Diseases) A new observational study has begun to evaluate the immune responses generated by COVID-19 vaccines administered to pregnant or postpartum people. Researchers will measure the development and durability of antibodies against SARS-CoV-2, the virus that causes COVID-19, in people vaccinated during pregnancy or the first two postpartum months. Researchers also will assess vaccine safety and evaluate the transfer of vaccine-induced antibodies to infants across the placenta and through breast milk.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news